Results
OneSource Q2 FY27 Revenue Up 37% YoY, Reaffirms FY28 Outlook
OneSource Specialty Pharma reported strong Q2 FY27 results with revenue up 37% YoY and EBITDA growing 53% YoY, driven by new DDC capacity.
The company's second sterile cartridge line is operational, d
